Integra Lifesciences Holdings Corp

NASDAQ: IART
$31.42
+$0.05 (+0.2%)
Closing Price on July 24, 2024

IART Chart and Intraday Price

IART Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address 1100 CAMPUS ROAD, PRINCETON, NJ, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 2,813.55M USD
Shares Outstanding 78,176,000
Integra LifeSciences Holdings Corp specializes in creating and distributing a wide range of medical devices and products aimed at enhancing surgical outcomes and patient care in neurosurgery, neurocritical care, and otolaryngology. With a focus on innovation, the company offers an extensive portfolio that includes surgical instruments, neurosurgical and critical care products, wound care solutions, and regenerative technology. Its products, known for their quality and reliability, are used by healthcare professionals in hospitals, surgery centers, and various medical offices around the globe. Founded in 1989 and based in Princeton, New Jersey, Integra is committed to advancing health care through its two main segments: Codman Specialty Surgical and Tissue Technologies.

IART Articles

Friday's top analyst upgrades and downgrades included Abercrombie & Fitch, Amazon.com, AMC Entertainment, Analog Devices, Discover Financial Services, Estee Lauder, Foot Locker, International Flavors...
The futures are positive after a strong risk-on Wednesday that saw all of the major indices close higher. The tailwind for stocks was provided by the June consumer-price-index numbers that saw...
Thursday's top analyst upgrades and downgrades included Antero Resources, AutoZone, Coterra Energy, Dollar General, Eli Lilly, First Horizon, Infosys, Owens Corning, Palo Alto Networks, Range...
Wednesday's top analyst upgrades and downgrades included Chevron, Cleveland-Cliffs, Infosys, Knight-Swift Transportation, Microsoft, Nucor, Salesforce, Steel Dynamics, Wheaton Precious Metals and...
Wednesday’s additional top analyst upgrades and downgrades included Humana, Nvidia, Thor and more.
Thursday's top analyst upgrades and downgrades included AT&T, Boeing, ConocoPhillips, Gilead Sciences, Illumina, Lam Research, Raytheon Technologies and Yum Brands.
The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators...
A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and other research calls from Monday include BlackRock, Capital One, Kroger, Nordstrom, Starbucks and Wells Fargo.
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney and Windstream.
Argus likes Integra’s strong growth prospects and its ability to execute on acquisition and mergers that help move the company's needle on growth in revenue and earnings.
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight move. Although...
Monday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, CVS Health, ConocoPhillips, EOG Resources, Seattle Genetics and WebMD.
Here are seven speculative biotech and biohealth players in which analyst calls during the week ending May 27 have given major upside projections.